Results 221 to 230 of about 1,389,478 (387)

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
EMPower the heArt of patients with TermInal Cancer using Cardiac medicines (EMPATICC). eGFR, estomated glomerular filtration rate; EP, endpoint; FCM, ferric carboxymaltose; LVEF, left ventricular ejection fraction; N‐terminal pro‐B‐type natriuretic peptide; PGA, patient global assessment; PoC, proof of concept; QoL, quality of life; UICC, Union for ...
Markus S. Anker   +23 more
wiley   +1 more source

Recurrent pulmonary embolism with haemoptysis, a challenging case. [PDF]

open access: yesLung India
Tripathi N   +4 more
europepmc   +1 more source

MASSIVE PULMONARY EMBOLISM [PDF]

open access: green, 1963
H. N. Wagner, R. Jones
openalex   +1 more source

Novel mutation associated with non‐compaction ventricular myocardium: A case report

open access: yes
ESC Heart Failure, EarlyView.
Yan Li   +4 more
wiley   +1 more source

Practical guide to management after an acute pulmonary embolism. [PDF]

open access: yesBMJ Open Respir Res
Alikhan R   +5 more
europepmc   +1 more source

Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy

open access: yesEuropean Journal of Heart Failure, EarlyView.
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy. CVF, left ventricular collagen volume fraction; DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; LV, left ventricular. Aims The need to perform endomyocardial biopsy (EMB) in patients with non‐ischaemic dilated cardiomyopathies (DCM) is debated ...
Elham Kayvanpour   +15 more
wiley   +1 more source

Massive Pulmonary Embolism:*

open access: green, 1964
Jorge O. Just-Viera, George H. Yeager
openalex   +2 more sources

Home - About - Disclaimer - Privacy